Advisor Group Holdings, Inc. Renalytix PLC Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Renalytix PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 10,685 shares of RNLX stock, worth $1,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,685

Previous 10,685 -0.0%

Holding current value

$1,602

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.23 - $0.93 $2,429 - $9,825	10,565 Added 8804.17%	10,685 $2,000
Q1 2024 May 10, 2024	SELL	$0.26 - $1.47 $166 - $940	-640 Reduced 84.21%	120 $0
Q4 2023 Feb 12, 2024	SELL	$0.33 - $1.61 $3,410 - $16,640	-10,336 Reduced 93.15%	760 $0
Q3 2023 Nov 13, 2023	BUY	$1.51 - $4.01 $2,496 - $6,628	1,653 Added 17.51%	11,096 $17,000
Q2 2023 Aug 10, 2023	SELL	$2.0 - $2.92 $2,354 - $3,436	-1,177 Reduced 11.08%	9,443 $27,000
Q1 2023 May 12, 2023	BUY	$1.93 - $3.72 $1,154 - $2,224	598 Added 5.97%	10,620 $25,000
Q4 2022 Feb 10, 2023	SELL	$1.06 - $2.21 $2,421 - $5,047	-2,284 Reduced 18.56%	10,022 $18,000
Q3 2022 Nov 14, 2022	BUY	$1.19 - $2.78 $92 - $216	78 Added 0.64%	12,306 $16,000
Q2 2022 Aug 10, 2022	BUY	$2.45 - $7.81 $563 - $1,796	230 Added 1.92%	12,228 $30,000
Q1 2022 May 04, 2022	BUY	$5.88 - $15.9 $38,020 - $102,809	6,466 Added 116.88%	11,998 $83,000
Q3 2021 Nov 05, 2021	BUY	$17.91 - $34.78 $66,231 - $128,616	3,698 Added 201.64%	5,532 $111,000
Q2 2021 Aug 02, 2021	BUY	$23.56 - $34.25 $43,209 - $62,814	1,834 New	1,834 $57,000
Q1 2021 May 13, 2021	SELL	$15.25 - $31.13 $7,625 - $15,565	-500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.18 - $17.3 $5,090 - $8,650	500 New	500 $6,000

Others Institutions Holding RNLX

# of Institutions

Shares Held

3.88M

Call Options Held

13.7K

Put Options Held

View Full List

About Renalytix plc

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

More about RNLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Renalytix PLC Transaction History